Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 15
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Borg, J Cervenka, S Kuja-Halkola, R Matheson, G J Jönsson, E G Lichtenstein, P Henningsson, S Ichimiya, T Larsson, H Stenkrona, P Halldin, C and Farde, L 2016. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Molecular Psychiatry, Vol. 21, Issue. 8, p. 1077.

    Howes, Oliver D. McCutcheon, Robert Owen, Michael J. and Murray, Robin 2016. The role of genes, stress and dopamine in the development of schizophrenia. Biological Psychiatry,

    Storozheva, Z. I. Kirenskaya, A. V. and Proshin, A. T. 2015. The neuromediator mechanisms of the cognitive deficit in schizophrenia. Neurochemical Journal, Vol. 9, Issue. 3, p. 186.

    Bonoldi, I. and Howes, O. D. 2014. Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis. CNS Drugs, Vol. 28, Issue. 7, p. 649.

    Diwadkar, Vaibhav A. Bustamante, Angela Rai, Harinder and Uddin, Monica 2014. Epigenetics, Stress, and Their Potential Impact on Brain Network Function: A Focus on the Schizophrenia Diatheses. Frontiers in Psychiatry, Vol. 5,

    Howes, Oliver D and Murray, Robin M 2014. Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, Vol. 383, Issue. 9929, p. 1677.

    Winton-Brown, Toby T. Fusar-Poli, Paolo Ungless, Mark A. and Howes, Oliver D. 2014. Dopaminergic basis of salience dysregulation in psychosis. Trends in Neurosciences, Vol. 37, Issue. 2, p. 85.

    Bonoldi, Ilaria and Howes, O.D. 2013. A New Era of Catecholamines in the Laboratory and Clinic.

    Fusar-Poli, P. and Meyer-Lindenberg, A. 2013. Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies. Schizophrenia Bulletin, Vol. 39, Issue. 1, p. 33.

    Howes, O. D. Williams, M. Ibrahim, K. Leung, G. Egerton, A. McGuire, P. K. and Turkheimer, F. 2013. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain, Vol. 136, Issue. 11, p. 3242.

    Howes, O. D. Shotbolt, P. Bloomfield, M. Daalman, K. Demjaha, A. Diederen, K. M. J. Ibrahim, K. Kim, E. McGuire, P. Kahn, R. S. and Sommer, I. E. 2013. Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations. Schizophrenia Bulletin, Vol. 39, Issue. 4, p. 807.

    Rao, Naren P and Remington, Gary 2013. Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials. Expert Opinion on Investigational Drugs, Vol. 22, Issue. 7, p. 881.

    Stokes, Paul R A Shotbolt, Paul Mehta, Mitul A Turkheimer, Eric Benecke, Aaf Copeland, Caroline Turkheimer, Federico E Lingford-Hughes, Anne R and Howes, Oliver D 2013. Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study. Neuropsychopharmacology, Vol. 38, Issue. 3, p. 485.

    Linden, David E.J. 2012. The Challenges and Promise of Neuroimaging in Psychiatry. Neuron, Vol. 73, Issue. 1, p. 8.

    Oertel-Knöchel, V. Knöchel, C. Matura, S. Rotarska-Jagiela, A. Magerkurth, J. Prvulovic, D. Haenschel, C. Hampel, H. and Linden, D.E.J. 2012. Cortical–basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives. Schizophrenia Research, Vol. 138, Issue. 2-3, p. 120.


Striatal dopamine synthesis capacity in twins discordant for schizophrenia

  • P. Shotbolt (a1), P. R. Stokes (a1), S. F. Owens (a2), T. Toulopoulou (a2), M. M. Picchioni (a2) (a3), S. K. Bose (a1), R. M. Murray (a2) and O. D. Howes (a1) (a2)
  • DOI:
  • Published online: 22 March 2011

Elevated striatal dopamine synthesis capacity is thought to be fundamental to the pathophysiology of schizophrenia and has also been reported in people at risk of psychosis. It is therefore unclear if striatal hyperdopaminergia is a vulnerability marker for schizophrenia, or a state feature related to the psychosis itself. Relatives of patients with schizophrenia are themselves at increased risk of developing the condition. In this study we examined striatal dopamine synthesis capacity in both members of twin pairs discordant for schizophrenia.


In vivo striatal dopamine synthesis capacity was examined using fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET) scans in seven twin pairs discordant for schizophrenia and in a control sample of 10 healthy control twin pairs.


Striatal 18F-DOPA uptake was not elevated in the unaffected co-twins of patients with schizophrenia (p=0.65) or indeed in the twins with schizophrenia (p=0.89) compared to the control group. Levels of psychotic symptoms were low in the patients with schizophrenia who were in general stable [mean (s.d.) Positive and Negative Syndrome Scale (PANSS) total=56.8 (25.5)] whereas the unaffected co-twins were largely asymptomatic.


Striatal dopamine synthesis capacity is not elevated in symptom-free individuals at genetic risk of schizophrenia, or in well-treated stable patients with chronic schizophrenia. These findings suggest that striatal hyperdopaminergia is not a vulnerability marker for schizophrenia.

Corresponding author
*Address for correspondence: Dr P. Shotbolt, Clinical Imaging Centre, Imperial College London, Du Cane Road, London W12 0NN, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

A Abi-Dargham , LS Kegeles , Y Zea-Ponce , O Mawlawi , D Martinez , V Mitropoulou , K O'Flynn , HW Koenigsberg , R Van Heertum , T Cooper , M Laruelle , LJ Siever (2004). Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biological Psychiatry 55, 10011006.

R Belmaker , W Pollin , RJ Wyatt , S Cohen (1974). A follow-up of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry 30, 219222.

MH Bhatt , BJ Snow , WR Martin , BD Pate , TJ Ruth , DB Calne (1991). Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Annals of Neurology 29, 673677.

SK Bose , FE Turkheimer , OD Howes , MA Mehta , R Cunliffe , PR Stokes , PM Grasby (2008). Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging. Schizophrenia Research 106, 148155.

TD Cannon , J Kaprio , J Lonnqvist , M Huttunen , M Koskenvuo (1998). The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Archives of General Psychiatry 55, 6774.

AG Cardno , II Gottesman (2000). Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. American Journal of Medical Genetics 97, 1217.

M Cordes , BJ Snow , S Cooper , M Schulzer , BD Pate , TJ Ruth , DB Calne (1994). Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Annals of Neurology 36, 667670.

A Dagher , R Gunn , G Lockwood , VJ Cunningham , PM Grasby , DJ Brooks (1998). Measuring neurotransmitter release with PET: methodological issues. In Quantitative Functional Brain Imaging with Positron Emission Tomography(ed. R. Carson , M. Daube-Witherspoon and P. Herscovitch ), pp. 449454. Academic Press: San Diego.

MH Dao-Castellana , ML Paillere-Martinot , P Hantraye , D Attar-Levy , P Remy , C Crouzel , E Artiges , A Feline , A Syrota , JL Martinot (1997). Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophrenia Research 23, 167174.

D Eidelberg , S Takikawa , V Dhawan , T Chaly , W Robeson , R Dahl , D Margouleff , JR Moeller , CS Patlak , S Fahn (1993). Striatal 18F-dopa uptake: absence of an aging effect. Journal of Cerebral Blood Flow and Metabolism 13, 881888.

AM Elkashef , D Doudet , T Bryant , RM Cohen , SH Li , RJ Wyatt (2000). 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Psychiatry Research 100, 111.

G Grunder , I Vernaleken , MJ Muller , E Davids , N Heydari , HG Buchholz , P Bartenstein , OL Munk , P Stoeter , DF Wong , A Gjedde , P Cumming (2003). Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology 28, 787794.

A Hammers , R Allom , MJ Koepp , SL Free , R Myers , L Lemieux , TN Mitchell , DJ Brooks , JS Duncan (2003). Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping 19, 224247.

J Hirvonen , TG van Erp , J Huttunen , S Aalto , K Nagren , M Huttunen , J Lonnqvist , J Kaprio , J Hietala , TD Cannon (2005). Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry 62, 371378.

OD Howes , A Egerton , V Allan , P McGuire , P Stokes , S Kapur (2009 a). Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Current Pharmacological Design 15, 25502559.

OD Howes , S Kapur (2009). The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophrenia Bulletin 35, 549562.

OD Howes , AJ Montgomery , MC Asselin , RM Murray , I Valli , P Tabraham , E Bramon-Bosch , L Valmaggia , L Johns , M Broome , PK McGuire , PM Grasby (2009 b). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 1320.

J Huttunen , M Heinimaa , T Svirskis , M Nyman , J Kajander , S Forsback , O Solin , T Ilonen , J Korkeila , T Ristkari , T McGlashan , RK Salokangas , J Hietala (2008). Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biological Psychiatry 63, 114117.

SR Kay , A Fiszbein , LA Opler (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261276.

M Laruelle , A Abi-Dargham , R Gil , L Kegeles , R Innis (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biological Psychiatry 46, 5672.

WR Martin , MR Palmer , CS Patlak , DB Calne (1989). Nigrostriatal function in humans studied with positron emission tomography. Annals of Neurology 26, 535542.

D Mamo , S Kapur , CM Shammi , G Papatheodorou , S Mann , F Therrien , G Remington (2004). A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. American Journal of Psychiatry 161, 818825.

D Martinez , M Slifstein , A Broft , O Mawlawi , DR Hwang , Y Huang , T Cooper , L Kegeles , E Zarahn , A Abi-Dargham , SN Haber , M Laruelle (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. Journal of Cerebral Blood Flow and Metabolism 23, 285300.

S McGowan , AD Lawrence , T Sales , D Quested , P Grasby (2004). Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Archives of General Psychiatry 61, 134142.

CS Patlak , RG Blasberg , JD Fenstermacher (1983). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Journal of Cerebral Blood Flow and Metabolism 3, 17.

GV Sawle , JG Colebatch , A Shah , DJ Brooks , CD Marsden , RS Frackowiak (1990). Striatal function in normal aging: implications for Parkinson's disease. Annals of Neurology 28, 799804.

R Smieskova , P Fusar-Poli , P Allen , K Bendfeldt , RD Stieglitz , J Drewe , EW Radue , PK McGuire , A Riecher-Rossler , SJ Borgwardt (2009). The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? – a systematic review. Current Pharmacological Design 15, 25352549.

RL Spitzer , JB Williams , M Gibbon , MB First (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry 49, 624629.

C Studholme , DL Hill , DJ Hawkes (1997). Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Medical Physics 24, 2535.

PF Sullivan , KS Kendler , MC Neale (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 11871192.

FE Turkheimer , JA Aston , MC Asselin , R Hinz (2006). Multi-resolution Bayesian regression in PET dynamic studies using wavelets. NeuroImage 32, 111121.

RL Williams (2000). A note on robust variance estimation for cluster-correlated data. Biometrics 56, 645646.

SW Woods (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663667.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *